Home > Chemicals & Materials > Polymers > Industrial Polymers > Medical Styrenic Block Copolymers (SBC) Market
Medical Styrenic Block Copolymers Market Size
Medical Styrenic Block Copolymers Market size was valued at over USD 600 million in 2022 and is poised to depict more than 7% CAGR from 2023 to 2032. The emerging health concerns and noticeable surge in demand for respiratory devices, oxygen masks, and other medical equipment will boost the demand for medical SBC over the forecast period.
Styrenic block polymers, especially polypropylene (PP), depict high clarity, durability, resilience, superior flexibility, and tensile strength. These characteristics make them suitable for utilization in a variety of medical and healthcare products, including transparent medical bottles, stoppers, syringes, vials, medical tubing, medical IV bags, ventilators, oxygen masks, etc.
Besides, the increasing healthcare investments triggered by the onset of fatal health calamities such as COVID-19 and the subsequent rise in the uptake of medical equipment for preventive therapies will further stimulate industry revenue streams.
Report Attributes | Details |
---|---|
Base Year: | 2022 |
Market Size in 2022: | USD 620 Million |
Forecast Period: | 2023 to 2032 |
Forecast Period 2023 to 2032 CAGR: | 7% |
2032 Value Projection: | USD 1.2 Billion |
Historical Data for: | 2018 to 2022 |
No. of Pages: | 240 |
Tables, Charts & Figures: | 200 |
Segments covered: | Product, Application |
Growth Drivers: |
|
Pitfalls & Challenges: |
|
High manufacturing costs and limited solvent bonding to restrict medical styrenic block copolymers market growth
Medical products manufactured through conventional techniques that make use of styrene block copolymers have slightly lower solvent bonding capacity than PVC-based equipment. These complexities have surged the requirement to introduce advanced design modifications, such as the use of additional adhesive solutions and luer design modifications in tubing dimensions to attain the desired solvent bonding. This may lead to numerous challenges in optimizing product manufacturing expenses and thus may impede medical SBC industry growth through the next ten years.
Medical Styrenic Block Copolymers Market Analysis
With regard to the product, Styrene Ethylene Butylene Styrene (SEBS) segment is slated to amass over USD 450 million by 2032. Styrene Ethylene Butylene Styrene (SEBS), a thermoplastic elastomer, depicts similar properties to that of rubber and thus is widely utilized as a potential alternative to natural rubber. The contaminant is highly flexible, easy to process, strong, and has exceptional resistance against heat and UV rays. The increasing product usage in manufacturing medical equipment, comprising tourniquets, surgical covers, blood separators, infusion tubes, rubber stoppers, etc. will favor segment growth through 2032.
Medical styrenic block copolymers market from equipment application segment is speculated to exceed USD 450 million by 2032, showcasing a more than 7% growth rate between 2023 and 2032. SBCs are witnessing high across the medical sector owing to their wide range of usage in several devices and equipment. The ongoing replacement of the existing medical equipment with polymer ones due to their enhanced design flexibility, low cost, and increased durability are set to boost segment share in the forthcoming years.
North America Medical SBC Market is projected to be worth over USD 500 million by 2032. North America is recognized by the strong presence of leading medical device and equipment manufacturers such as Stryker, 3M Company, Intuitive Surgical, Medtronic, Abbott Laboratories, and Johnson & Johnson in countries such as the U.S. and Canada. The robust competitive landscape, a wide customer base, and the accelerating shift from PVC-based materials toward SBCs will support the regional expansion.
Medical Styrenic Block Copolymers Market Share
Notable players in the medical styrenic block copolymers market are :
- Kraton Corporation
- TSRC Corporation
- China Petroleum & Chemical Corporation
- LG Chem
- Dynasol Group
- Asahi Kasei Corporation
- Kumho Petrochemical
- LCY Chemical Corp
- INEOS Styrolution Group GmbH,
- JSR Corporation
- RTP Company
- Zeon Corporation
- En Chuan Chemical Industries Co., Ltd.
- Trinseo SA.
Impact of COVID-19 Pandemic
Medical styrenic block copolymers (SBC) industry witnessed lucrative growth during the pandemic. The sudden upsurge in COVID-19 infections and the significant rise in hospital admissions and patients undergoing preventive respiratory therapies massively boosted the demand for medical equipment such as oxygen masks, ventilators, drug delivery devices, etc. In addition, the governments across several economies adopted necessary growth measures and infused significant investments to aid the declining healthcare infrastructure, which further facilitated the industry expansion during the crisis and is expected to continue doing so in the approaching years as well.
The Medical Styrenic Block Copolymers Market research report includes in-depth coverage of the industry with estimates & forecasts in terms of volume in kilo tons & in terms of revenue in USD million from 2018 to 2032 for the following segments:
Click here to Buy Section of this Report
By Product
- Styrene-Butadiene-Styrene (SBS)
- Styrene Isoprene Butadiene (SIBS)
- Styrene Ethylene Butylene Styrene (SEBS)
- Others
By Application
- Tubing
- Medical Bags
- Equipment’s
- Packaging & Diagnostics Products
- Wound Care
- Others
The above information is provided on a regional and country basis for the following:
- North America
- U.S.
- Canada
- Europe
- Germany
- UK
- France
- Spain
- Italy
- Russia
- Asia Pacific
- China
- India
- Japan
- Taiwan
- South Korea
- Indonesia
- Malaysia
- Latin America
- Brazil
- Mexico
- Middle East & Africa
- Saudi Arabia
- UAE
- South Africa
- Israel
Frequently Asked Questions (FAQ) :